(R)-1-(5-Hydroxyhexyl)-3,7-Dimethyl-1H-Purine-2,6(3H,7H)-Dione

(R)-Lisofylline is primarily being researched for its potential applications in:

• Type 1 Diabetes Treatment: Its ability to prevent diabetes onset in preclinical models positions it as a promising therapeutic agent.
• Anti-inflammatory Therapy: Given its mechanism of action against inflammatory cytokines, it may also be beneficial in treating other inflammatory conditions.
• Mitochondrial Function Improvement: Its effects on cellular metabolism could open avenues for treating metabolic disorders associated with diabetes.

The biological activity of (R)-Lisofylline is primarily linked to its anti-inflammatory effects. It has been demonstrated to protect pancreatic β-cells from dysfunction induced by Th1 cytokines, which are often implicated in autoimmune damage associated with Type 1 Diabetes. Additionally, (R)-Lisofylline enhances mitochondrial function in cells and improves the viability of isolated or transplanted pancreatic islets, making it a candidate for diabetes treatment.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.